Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Gastroenterology. 2009 Mar 18;137(1):209–220. doi: 10.1053/j.gastro.2009.03.007

Figure 5. TFF3 supplementation rescues TLR2-deficient mice from colitis-induced lethality.

Figure 5

Survival rate of TLR2−/− mice (n=5 per group) that first received 4.0% DSS for 5 days followed by rescue therapy with recombinant TFF3 (0.4mg/ml p.o.) or water for 6 subsequent days. Mice were then followed up to day 21 after DSS start.